Looking At AbbVie’s Recent Unusual Options Activity

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking…

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie.

Looking at options history for AbbVie (NYSE:ABBV) we detected 11 strange trades.

If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 63% with bearish.

From the overall spotted trades, 5 are puts, for a total amount of $266,154 and 6, calls, for a total amount of $251,565.

What’s The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $120.0 to $180.0 for AbbVie over the last 3 months.

Volume & Open Interest Development

In terms of liquidity and interest, the mean open interest for AbbVie options trades today is 1478.5 with a total volume of 1,496.00.

In the following chart, we are able to follow the development of volume and open interest of call and put options for AbbVie’s big money trades within a strike price range of $120.0 to $180.0 over the last 30 days.

AbbVie Option Volume And Open Interest Over Last 30 Days

Options Call Chart

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
ABBV PUT SWEEP BULLISH 07/21/23 $135.00 $139.2K 275 865
ABBV CALL TRADE BEARISH 07/21/23 $120.00 $62.7K 18 25
ABBV CALL TRADE BEARISH 07/21/23 $150.00 $62.2K 412 162
ABBV CALL TRADE BULLISH 01/17/25 $145.00 $38.3K 8.9K 36
ABBV PUT TRADE BEARISH 06/16/23 $180.00 $32.6K 31 10

Where Is AbbVie Standing Right Now?

  • With a volume of 3,680,510, the price of ABBV is down -0.41% at $147.42.
  • RSI indicators hint that the underlying stock may be approaching oversold.
  • Next earnings are expected to be released in 81 days.

What The Experts Say On AbbVie:

  • Guggenheim has decided to maintain their Buy rating on AbbVie, which currently sits at a price target of $171.
  • Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $181.
  • Wells Fargo has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $195.
  • Morgan Stanley has decided to maintain their Overweight rating on AbbVie, which currently sits at a price target of $182.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for AbbVie, Benzinga Pro gives you real-time options trades alerts.

Total
0
Shares
Related Posts
Read More

Martin Midstream Partners And 3 Other Penny Stocks Insiders Are Buying

The Dow Jones closed higher by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

BCOV

Read More

Affordable Housing, Less Carbon: DOE Funds Texas A&M University 3D-Printed Hempcrete Project

The Department of Energy (DOE) has awarded Texas A&M University $3.47 million to support a project to 3D print a bio-aggregate composite consisting of hemp hurd and a lime-based binder, also known as hempcrete, a material with the potential to lower the environmental impact of traditional construction and make housing more affordable and available,

OWPC